EP Patent

EP2968268B1 — Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase

Assigned to Concert Pharmaceuticals Inc · Expires 2020-07-29 · 6y expired

What this patent protects

Patent listed against eliglustat-tartrate.

Drugs covered by this patent

eliglustat-tartrate (ELIGLUSTAT TARTRATE)

Patent Metadata

Patent number: EP2968268B1
Jurisdiction: EP
Classification: —
Expires: 2020-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Concert Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.